Abeer A Al Rabayah
King Hussein Cancer Center
Abeer A Al Rabayah is listed at King Hussein Cancer Center. B2DB records 3 sessions at 1 conference in 2026, most recently ISPOR Europe 2026 (November 2026). Roles on record: moderator 2. Speaks mainly at Hospitals and Health Care events.
Compiled from published conference agendas; not yet confirmed by Abeer. Is this you? Claim this profile.
- Sector: Hospitals and Health Care
About
Dr. Abeer Ahmad Al Rabayah leads the Center for Drug Policy and Technology Assessment (CDPTA) at the King Hussein Cancer Center (KHCC) in Amman, Jordan. In addition to her role at KHCC, Dr. Abeer holds a research associate position at the Institute of Public Health, Medical Decision Making, and Health Technology Assessment at UMIT TIROL – University for Health Sciences and Technology, Hall i.T., Austria. As the director of the Hospital-Based Health Technology Assessment (HB-HTA) program and the founder of the Health Technology Assessment (HTA) fellowship program at KHCC, In 2024, the KHCC HB-HTA program received the King Hussein Cancer Research Award for Academic Program Excellence. Dr. Abeer has significantly contributed to the field. She has authored over 20 publications in HTA and Health Economics research, covering areas such as decision analytical modeling, HTA processes and methods, valuation of health outcomes, and Health-Related Quality of Life research. Dr. Abeer is influentia
Sessions at 1 conference
ISPOR Europe 2026 8 November 2026 – 11 November 2026
- Beyond the Index Event: Aligning Hospital Decision-Making with Expanded Value Measures for Medical Devices and Diagnostics Speaker · 9 November 2026
- Case Studies in Med Tech Evaluation Moderator · 9 November 2026
- Oncology Poster Tour Moderator · 9 November 2026
Spoke alongside
People who have shared a session with Abeer at events on B2DB.
- Sally Lewis Independent Healthcare Consultant · Kintsugi-international.com 1 shared session
- Belinda A Mohr HEOR Consultant · Medtronic 1 shared session
- Claudia Roeder Director, Evidence and Value Development CM&E and Fertility · Merck Healthcare 1 shared session
- Fatima Wafqui Mohammed VI Center for Research and Innovation 1 shared session
- Koen Degeling GSK Netherlands 1 shared session
- Lisa Masucci The Ottawa Hospital 1 shared session
- Marjan Hummel Philips 1 shared session
- Sukhvinder S. Johal Health Economics & Payer Evidence Director · AstraZeneca 1 shared session